You are here: Home » Reuters » News
Business Standard

Dow down for fifth straight day as global trade war fear weighs

Eight of 11 S&P 500 indexes were lower on Monday, led by financials and information technology

Reuters 

Dow
A trader works on the floor at the New York Stock Exchange (NYSE) in Manhattan (Photo: Reuters)

The fell for the fifth straight day on Monday as concerns about a global trade war following Donald Trump's threat to impose hefty tariffs kept investors on the edge.

Trump on Monday appeared to suggest that and could win exemptions to the planned sweeping tariffs on and aluminum if the two countries sign a new NAFTA trade deal and take other steps.

The ended another rocky week on an upbeat note on Friday, but major indexes still posted their worst week of losses since early February after Trump promised tariffs on aluminum and and talked bullishly about "winning" a trade war economists say could decimate growth.

"The just tweeted a while ago, sounding tough on trade with and Mexico," said Scott Brown, at in St. Petersburg,

"Some of it will get passed on to consumers in terms of higher prices ...

It'll add a little bit to inflation. But I think it's more an uncertainty," Brown added.

Eight of 11 indexes were lower on Monday, led by financials and

World stocks and emerging markets fell for the fifth straight day on Monday, with investors also worrying that Italian voters had flocked to anti-establishment and far-right groups in record numbers and had delivered a hung parliament.

Investors dumped stocks in favor of traditional safe havens including gold and the Japanese yen, with gold touching a near one-week high on Monday.

"Markets' inability to regain confidence is likely to keep stocks defensive," said.

At 9:41 a.m. EDT, the was down 64.93 points, or 0.26 percent, at 24,473.13, the was down 6.76 points, or 0.251184 percent, at 2,684.49 and the was down 20.10 points, or 0.28 percent, at 7,237.76.

Shares in chipmaker dipped 1.6 percent after the in the (CFIUS) ordered the company to postpone an annual shareholder meeting, giving it more time to resist efforts by to force through a $117 billion merger.

Shares of jumped 55 percent after the drug developer's eye drug met the main goal in a late-stage study, while plunged 60 percent after the company abandoned its acne drug.

Europe's second-biggest insurer rose 30 percent after being acquired by France's AXA for $15.3 billion.

First Published: Mon, March 05 2018. 21:25 IST
RECOMMENDED FOR YOU